{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:11:07Z","timestamp":1790637067098,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-17-EURE-0022"],"award-info":[{"award-number":["ANR-17-EURE-0022"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003768","name":"Universit\u00e9 de Strasbourg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003768","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ejphar.2018.12.018","type":"journal-article","created":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T12:39:29Z","timestamp":1544618369000},"page":"316-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Analgesic and anti-edemic properties of etifoxine in models of inflammatory sensitization"],"prefix":"10.1016","volume":"843","author":[{"given":"G\u00e9raldine","family":"Gazzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisrine","family":"Kamoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Verleye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierrick","family":"Poisbeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.12.018_bib1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pain.2009.08.001","article-title":"Reduction and prevention of vincristine-induced neuropathic pain symptoms by the non-benzodiazepine anxiolytic etifoxine are mediated by 3alpha-reduced neurosteroids","volume":"147","author":"Aouad","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2018.12.018_bib2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/j.1532-2149.2013.00367.x","article-title":"Etifoxine stimulates allopregnanolone synthesis in the spinal cord to produce analgesia in experimental mononeuropathy","volume":"18","author":"Aouad","year":"2014","journal-title":"Eur. J. Pain."},{"key":"10.1016\/j.ejphar.2018.12.018_bib3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.pain.2013.11.003","article-title":"Etifoxine analgesia in experimental monoarthritis: a combined action that protects spinal inhibition and limits central inflammatory processes","volume":"155","author":"Aouad","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2018.12.018_bib4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/emmm.201202124","article-title":"A TSPO ligand is protective in a mouse model of multiple sclerosis","volume":"5","author":"Daugherty","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejphar.2018.12.018_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0304-3959(77)90130-0","article-title":"The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats","volume":"4","author":"Dubuisson","year":"1977","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2018.12.018_bib6","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1530\/JME-12-0127","article-title":"Neuroactive steroids, their metabolites, and neuroinflammation","volume":"49","author":"Giatti","year":"2012","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.ejphar.2018.12.018_bib7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2826.2011.02215.x","article-title":"Axonal regeneration and neuroinflammation: roles for the translocator protein 18 kDa","volume":"24","author":"Girard","year":"2012","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.ejphar.2018.12.018_bib8","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1440-1681.2008.05127.x","article-title":"Preventive and curative effects of etifoxine in a rat model of brain oedema","volume":"36","author":"Girard","year":"2009","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejphar.2018.12.018_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(95)00302-2","article-title":"Etodolac selectively inhibits human prostaglandin G\/H synthase 2 (PGHS-2) versus human PGHS-1","volume":"281","author":"Glaser","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.12.018_bib10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0028-3908(03)00187-4","article-title":"The modulatory effects of the anxiolytic etifoxine on GABA(A) receptors are mediated by the beta subunit","volume":"45","author":"Hamon","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2018.12.018_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","article-title":"A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia","volume":"32","author":"Hargreaves","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2018.12.018_bib12","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1126\/science.1094925","article-title":"GlyRalpha3: an essential target for spinal PGE2-mediated inflammatory pain sensitization","volume":"304","author":"Harvey","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2018.12.018_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neurobiolaging.2016.02.029","article-title":"Progesterone exerts neuroprotective effects and improves long-term neurologic outcome after intracerebral hemorrhage in middle-aged mice","volume":"42","author":"Jiang","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejphar.2018.12.018_bib14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1159\/000442204","article-title":"Progesterone improves neurobehavioral outcome in models of intracerebral hemorrhage","volume":"103","author":"Lei","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ejphar.2018.12.018_bib15","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1096\/fj.201601377RR","article-title":"A TSPO ligand attenuates brain injury after intracerebral hemorrhage","volume":"31","author":"Li","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2018.12.018_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jpain.2005.07.011","article-title":"Calibrated forceps: a sensitive and reliable tool for pain and analgesia studies","volume":"7","author":"Luis-Delgado","year":"2006","journal-title":"J. Pain."},{"key":"10.1016\/j.ejphar.2018.12.018_bib17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0006-8993(02)02593-3","article-title":"Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury","volume":"937","author":"Ma","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2018.12.018_bib18","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrn3946","article-title":"Crosstalk between the nociceptive and immune systems in host defence and disease","volume":"16","author":"McMahon","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2018.12.018_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1472-8206.2001.00025.x","article-title":"A double blind parallel group placebo controlled comparison of sedative and mnesic effects of etifoxine and lorazepam in healthy subjects [corrected]","volume":"15","author":"Micallef","year":"2001","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.12.018_bib20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.nbd.2004.05.010","article-title":"Inflammation alters cation chloride cotransporter expression in sensory neurons","volume":"17","author":"Morales-Aza","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2018.12.018_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/hup.757","article-title":"Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice","volume":"21","author":"Nguyen","year":"2006","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2018.12.018_bib22","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/BF03013041","article-title":"Intrathecal ketorolac tromethamine produces analgesia after chronic constriction injury of sciatic nerve in rat","volume":"43","author":"Parris","year":"1996","journal-title":"Can. J. Anaesth."},{"key":"10.1016\/j.ejphar.2018.12.018_bib23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ejphar.2012.10.019","article-title":"The role of PKC\/ERK1\/2 signaling in the anti-inflammatory effect of tetracyclic triterpene euphol on TPA-induced skin inflammation in mice","volume":"698","author":"Passos","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.12.018_bib24","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fncel.2014.00174","article-title":"Analgesic strategies aimed at stimulating the endogenous production of allopregnanolone","volume":"8","author":"Poisbeau","year":"2014","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.ejphar.2018.12.018_bib25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neuropharm.2016.03.053","article-title":"Differential efficacy of the TSPO ligands etifoxine and XBD-173 in two rodent models of Multiple Sclerosis","volume":"108","author":"Ravikumar","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2018.12.018_bib26","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0028-3908(99)00253-1","article-title":"Modulation of GABAergic synaptic transmission by the non-benzodiazepine anxiolytic etifoxine","volume":"39","author":"Schlichter","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2018.12.018_bib27","first-page":"569","article-title":"Treatment of adjustment disorder with anxiety: efficacy and tolerance of etifoxine in a double-blind controlled study","volume":"24","author":"Servant","year":"1998","journal-title":"Encephale"},{"key":"10.1016\/j.ejphar.2018.12.018_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12974-016-0687-3","article-title":"Etifoxine improves sensorimotor deficits and reduces glial activation, neuronal degeneration, and neuroinflammation in a rat model of traumatic brain injury","volume":"13","author":"Simon-O'Brien","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.ejphar.2018.12.018_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12325-015-0176-6","article-title":"Etifoxine versus alprazolam for the treatment of adjustment disorder with anxiety: a randomized controlled trial","volume":"32","author":"Stein","year":"2015","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ejphar.2018.12.018_bib30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.brainres.2007.09.041","article-title":"Neurosteroid allopregnanolone mediates anxiolytic effect of etifoxine in rats","volume":"1184","author":"Ugale","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2018.12.018_bib31","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1152\/jn.01091.2005","article-title":"Role of the Na+-K+\u22122Cl- cotransporter in the development of capsaicin-induced neurogenic inflammation","volume":"95","author":"Valencia-de Ita","year":"2006","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.ejphar.2018.12.018_bib32","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.pbb.2005.11.013","article-title":"The anxiolytic etifoxine activates the peripheral benzodiazepine receptor and increases the neurosteroid levels in rat brain","volume":"82","author":"Verleye","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2018.12.018_bib33","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-111-27849","article-title":"Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs","volume":"111","author":"Winter","year":"1962","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.ejphar.2018.12.018_bib34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1055\/s-0035-1558003","article-title":"Enhancing neurosteroid synthesis--relationship to the pharmacology of translocator protein (18 kDa) (TSPO) ligands and benzodiazepines","volume":"48","author":"Wolf","year":"2015","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.ejphar.2018.12.018_bib35","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1523\/JNEUROSCI.21-16-05847.2001","article-title":"The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1","volume":"21","author":"Yaksh","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2018.12.018_bib36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev-pharmtox-010611-134636","article-title":"Chronic pain states: pharmacological strategies to restore diminished inhibitory spinal pain control","volume":"52","author":"Zeilhofer","year":"2012","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2018.12.018_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0304-3959(02)00465-7","article-title":"Cyclooxygenase-1 in the spinal cord plays an important role in postoperative pain","volume":"104","author":"Zhu","year":"2003","journal-title":"Pain"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918307234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918307234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:06:45Z","timestamp":1762142805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918307234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":37,"alternative-id":["S0014299918307234"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.12.018","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analgesic and anti-edemic properties of etifoxine in models of inflammatory sensitization","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}